The U.S. Food and Drug Administration has authorized updated COVID-19 vaccines targeting higher-risk groups, allowing manufacturers to distribute new mRNA-based formulations from two major pharmaceutical companies. Alongside the familiar mRNA technology, the agency also approved a non-mRNA vaccine option, expanding available choices for eligible individuals. The move follows regulatory review and comes as health officials continue adapting responses to evolving public health needs. Pharmacies and medical providers are now preparing to administer the newly cleared shots.
The Food and Drug Administration approved updated COVID-19 vaccines on Thursday for people at higher risk, clearing the way for manufacturers to begin shipping them to pharmacies and physicians' offices. The agency greenlit new formulations of the mRNA vaccines from Pfizer-BioNTech and Moderna, the companies said. FDA also approved a non-mRNA shot from Sanofi, which...
